EarningsQ4 2024 Earnings Report

Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Report

0 Followers

MX:VRTX Q4 2024 EPS Results

Actual EPS$67.54

Consensus EPS$68.15

Beat/MissMissed by -$0.61

One Year Ago EPS$71.27

Actual Revenue$49.00B

Expected Revenue$47.25B

Beat/MissBeat by +$1.75B

YoY Revenue Growth+14.56%

QuarterQ4 2024

Date02/10/2025

TimeAfter Close

Conference CallMonday, February 10, 2025

MX:VRTX Upcoming Earnings

Vertex Pharmaceuticals's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

MX:VRTX Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 09, 2026	2026 (Q3)	80.96 / -	81.457	―
Aug 03, 2026	2026 (Q2)	80.46 / 80.27	76.705	4.65% (+3.56)
May 04, 2026	2026 (Q1)	72.00 / 75.86	68.899	10.10% (+6.96)
Feb 12, 2026	2025 (Q4)	86.73 / 85.36	67.541	26.38% (+17.82)
Nov 03, 2025	2025 (Q3)	77.60 / 81.46	74.329	9.59% (+7.13)
Aug 06, 2025	2025 (Q2)	72.77 / 76.71	-217.727	135.23% (+294.43)
May 05, 2025	2025 (Q1)	73.26 / 68.90	80.778	-14.71% (-11.88)
Feb 10, 2025	2024 (Q4)	68.15 / 67.54	71.275	-5.24% (-3.73)
Nov 04, 2024	2024 (Q3)	69.20 / 74.33	69.238	7.35% (+5.09)
Aug 01, 2024	2024 (Q2)	-197.29 / -217.73	66.014	-429.82% (-283.74)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed